SRX Global sells 3,579 Series C preferred shares in private placement valued at $2.86 million

PUBT · 2d ago
SRX Global sells 3,579 Series C preferred shares in private placement valued at $2.86 million
  • SRX Global entered a private placement on Aug. 27, 2026, issuing 3,579 shares of Series C convertible preferred stock.
  • Investors paid USD 2.86 million via assignment of CERO Therapeutics Convertible Grid Promissory Notes with USD 2.81 million principal.
  • Series C preferred carries a USD 1,000 stated value per share.
  • The security ranks senior to common stock, pari passu with Series A and Series B preferred stock.
  • Holders receive dividends on an as-converted basis, matching any dividends paid on common stock.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SRX Global Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-040642), on August 28, 2026, and is solely responsible for the information contained therein.